Activin and Inhibin

CDK9-IN-7 (compound 21e) is a selective, highly potent, and orally active CDK9/cyclin T inhibitor ( IC 50 =11 nM), which exhibits more potent over other CDKs (CDK4/cyclinD=148 nM: CDK6/cyclinD=145 nM). CDK9-IN-7 shows antitumor activity without

CDK9-IN-7 (compound 21e) is a selective, highly potent, and orally active CDK9/cyclin T inhibitor ( IC 50 =11 nM), which exhibits more potent over other CDKs (CDK4/cyclinD=148 nM: CDK6/cyclinD=145 nM). CDK9-IN-7 shows antitumor activity without

CDK9-IN-8 is a highly effective and selective CDK9 inhibitor with an IC 50 of 12 nM.Form:SolidIC50&amp: Target:CDK9 12 nM (IC 50 ).

CDK9-IN-8 is a highly effective and selective CDK9 inhibitor with an IC 50 of 12 nM.Form:SolidIC50&amp: Target:CDK9 12 nM (IC 50 ).

CDK9-IN-8 is a highly effective and selective CDK9 inhibitor with an IC 50 of 12 nM.Form:SolidIC50&amp: Target:CDK9 12 nM (IC 50 ).

CDK9-IN-8 is a highly effective and selective CDK9 inhibitor with an IC 50 of 12 nM.Form:SolidIC50&amp: Target:CDK9 12 nM (IC 50 ).

Cebranopadol ((1α,4α)stereoisomer) is a stereoisomer of cebranopadol. Cebranopadol is a potent agonist activity on ORL-1.Form:Solid.

Cebranopadol ((1α,4α)stereoisomer) is a stereoisomer of cebranopadol. Cebranopadol is a potent agonist activity on ORL-1.Form:Solid.

Cefazolin sodium salt inhibits synthesis of bacterial cell wall.An inhibitor of bacterial cell wall synthesis.

Cefazolin sodium salt inhibits synthesis of bacterial cell wall.An inhibitor of bacterial cell wall synthesis.

Cefazolin sodium salt inhibits synthesis of bacterial cell wall.An inhibitor of bacterial cell wall synthesis.

Cefazolin sodium salt inhibits synthesis of bacterial cell wall.An inhibitor of bacterial cell wall synthesis.